Skip to main content
×
Home
    • Aa
    • Aa

“Meta-guidelines” for the management of patients with schizophrenia

  • Stephen M. Stahl (a1) (a2) (a3) (a4), Debbi A. Morrissette (a3), Leslie Citrome (a5), Stephen R. Saklad (a6) (a7) (a8), Michael A. Cummings (a4), Jonathan M. Meyer (a1) (a4), Jennifer A. O'Day (a4), Laura J. Dardashti (a4) and Katherine D. Warburton (a4)...
Abstract

Guidelines for treating various conditions can be helpful in setting practice standards, but the presence of several sets of guidelines from different countries, experts, and settings, written at different times, can also create confusion. Here we provide a “guideline of guidelines” for the treatment of schizophrenia, or “meta-guidelines,” which not only reconcile the various existing standards but also update them to include the use of several newer agents, most of which were marketed following the publication of existing standards.

Copyright
Corresponding author
*Address for correspondence: Stephen M. Stahl, MD, PhD, 1930 Palomar Point Way, Suite 103, Carlsbad, CA 92008, USA. (Email smstahl@neiglobal.com)
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

4.TA Moore , RW Buchanan , PF Buckley , etal. The Texas Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. J Clin Psychiatry. 2007; 68(11): 17511762.

6.RW Buchanan , J Kreyenbuhl , DL Kelly , etal. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull. 2010; 36(1): 7193.

7.LB Dixon , F Dickerson , AS Bellack , etal. The 2009 PORT psychosocial treatment recommendations and summary statements. Schizophr Bull. 2010; 36(1): 4870.

8.J Kreyenbuhl , RW Buchanan , FB Dickerson , etal. The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009. Schizophr Bull. 2010; 36(1): 94103.

9.SM Stahl . How to dose a psychotropic drug: beyond therapeutic drug monitoring to genotyping the patient. Acta Psychiatr Scand. 2010; 122: 440441.

10.SM Stahl . Antipsychotic polypharmacy: never say never, but never say always. Acta Psychiatr Scand. 2012; 125: 349351.

11.SM Stahl . The tyranny of the majority and the interchangeability of drugs. Acta Psychiatr Scand. 2013; 127: 45.

12.SM Stahl , DA Morrissette . Should high dose or very long term antipsychotic monotherapy be considered before antipsychotic polypharmacy? In: Ritsner MS, ed. Polypharmacy in Psychiatry Practice, Volume I: Use of Polypharmacy in the “Real World”. Dordrecht, The Netherlands: Springer Science; 2013.

13.MS Ritsner , ed. Polypharmacy in Psychiatry Practice, Volume I: Multiple Medication Use Strategies. Dordrecht, The Netherlands: Springer Science; 2013.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

CNS Spectrums
  • ISSN: 1092-8529
  • EISSN: 2165-6509
  • URL: /core/journals/cns-spectrums
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: